Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: A randomized, double-blind, placebo-controlled study of ε-aminocaproic acid and aprotinin

Philip E Greilich, Chad F. Brouse, Charles W Whitten, Lei Chi, J. Michael DiMaio, Michael E Jessen

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: A randomized, double-blind, placebo-controlled study of ε-aminocaproic acid and aprotinin'. Together they form a unique fingerprint.

Medicine & Life Sciences